Market Overview

UPDATE: Longbow Upgrades Chemtura to Buy on Margin Enhancement and Portfolio Evolution

Related CHMT
Chemtura Names Simon Medley Executive VP, Industrial Performance Products And Great Lakes Solutions
Benzinga's Top Downgrades

Longbow raised its rating on Chemtura (NYSE: CHMT) from Neutral to Buy with a $26 price target.

Longbow commented, "We are upgrading our investment rating of CHMT to BUY from NEUTRAL with a 12-month target price of $26 on greater confidence in management's ability to outperform expectations in the near-term. Sustainable improvements in AgroSolutions, a compelling strategic rationale for the Solaris deal and expectations of further growth in Engineered Products, combined with further portfolio optimization should generate meaningful shareholder value expansion over a 12-24 month period."

Chemtura closed at $20.44 on Wednesday.

Latest Ratings for CHMT

DateFirmActionFromTo
Sep 2014KeyBancDowngradesBuyHold
Jul 2013Piper JaffrayMaintainsOverweight
Jun 2013OppenheimerDowngradesMarket PerformUnderperform

View More Analyst Ratings for CHMT
View the Latest Analyst Ratings

Posted-In: LongbowAnalyst Color Upgrades Intraday Update Analyst Ratings

 

Related Articles (CHMT)

Around the Web, We're Loving...

Get Benzinga's Newsletters